Latest News
Feature
FTC Interim Report on Pharmacy Middlemen Is First Step of Many Needed in Addressing Drug Costs, Access
Madelaine Feldman, MD, has been a vocal PBM critic for years. She sees a recent FTC interim report as evidence of the need for congressional...
Latest News
CBD Use in Pregnant People Double That of Nonpregnant Counterparts
Use for mental and physical relief is growing faster than data on potential outcomes for exposed offspring.
Latest News
Type 2 Diabetes Fracture Risk Likely Due to Impaired Physical Function
Despite having higher bone mineral density, older women with type 2 diabetes have higher fracture risk and poorer physical performance than older...
Commentary
What Would ‘Project 2025’ Mean for Health and Healthcare?
Conservative group–backed plan intends to alter the processes and/or funding of CDC, NIH, Medicaid, and other agencies.
From the Journals
New Biological Pathway May Explain BPA Exposure, Autism Link
Silencing a key enzyme, aromatase, that controls neurohormones and is especially important in fetal male brain development, may be associated with...
Latest News
Is Buprenorphine/Naloxone Safer Than Buprenorphine Alone During Pregnancy?
“For the outcomes assessed, compared with buprenorphine alone, buprenorphine combined with naloxone during pregnancy appears to be a safe...
Latest News
PCOS Increases Eating Disorder Risk
Women with PCOS had 53% higher odds of any eating disorder than control individuals without PCOS; disordered eating scores were higher in both the...
Latest News
Sexual Arousal Cream Promising in Some Subsets of Women
While topical sildenafil cream did not show significant improvement in arousal disorder based on a study’s main endpoints, it did show...
Latest News
Study Identifies Oral Antibiotics Linked to Severe Cutaneous Reactions
The results “underscore the importance of judicious prescribing, with preferential use of antibiotics associated with a lower risk when clinically...
From the Journals
Pure Mucinous Breast Cancer Shows Better Survival Rates Than Other Subtypes
Researchers analyzed data from 23,102 women diagnosed with hormone receptor–positive HER2-negative stage I-III breast cancer.
Latest News
How Safe is Anti–IL-6 Therapy During Pregnancy?
Transient neonatal cytopenia was the only possible adverse outcome that could be related to anti–IL-6 therapy.